MicroRNA‐410 serves as a candidate biomarker in hypoxic‐ischemic encephalopathy newborns and provides neuroprotection in oxygen‐glucose deprivation‐injured PC12 and SH‐SY5Y cells

BACKGROUND: MicroRNA‐410 (miR‐410) has been found to be deregulated in neonatal hypoxic‐ischemic encephalopathy (HIE). However, the clinical significance and biological function of miR‐410 remain largely elusive. This study aims to investigate the expression and diagnostic performance of miR‐410 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Qinghong, Yang, Peipei, Lu, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413830/
https://www.ncbi.nlm.nih.gov/pubmed/34331407
http://dx.doi.org/10.1002/brb3.2293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413830/
https://www.ncbi.nlm.nih.gov/pubmed/34331407
http://dx.doi.org/10.1002/brb3.2293

Ejemplares similares